Acute Renal Failure Pharmaceutical and Healthcare Pipeline Review H2
Feb 22, 2017
WiseGuyReports.com adds Exclusive Research on “Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2016” reports to its database.
Pune, India - February 22, 2017 /MarketersMedia/ —
The report provides comprehensive information on the therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/383551-acute-renal-failure-arf-acute-kidney-injury-pipeline-review-h1-2016
Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global therapeutic landscape of Acute Renal Failure (ARF) (Acute Kidney Injury)
- The report reviews pipeline therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury) by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Acute Renal Failure (ARF) (Acute Kidney Injury) therapeutics and enlists all their major and minor projects
- The report assesses Acute Renal Failure (ARF) (Acute Kidney Injury) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury)
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Content: Key Points
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Acute Renal Failure (ARF) (Acute Kidney Injury) Overview 10
Therapeutics Development 11
Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) - Overview 11
Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) - Comparative Analysis 12
Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics under Development by Companies 13
Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics under Investigation by Universities/Institutes 15
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Products Glance 16
Clinical Stage Products 16
Early Stage Products 17
Acute Renal Failure (ARF) (Acute Kidney Injury) - Products under Development by Companies 18
Acute Renal Failure (ARF) (Acute Kidney Injury) - Products under Investigation by Universities/Institutes 20
Acute Renal Failure (ARF) (Acute Kidney Injury) - Companies Involved in Therapeutics Development 21
A1M Pharma AB 21
Adrenomed AG 22
Am-Pharma B.V. 23
Angion Biomedica Corp. 24
Atox Bio Inc. 25
Cellmid Limited 26
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/383551-acute-renal-failure-arf-acute-kidney-injury-pipeline-review-h1-2016
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349
Source URL: http://marketersmedia.com/acute-renal-failure-pharmaceutical-and-healthcare-pipeline-review-h2/172223
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 172223
More News
People Are Revealing Which Vacation Destinations Scream MAGA Versus Democrat
I mean... there is some truth to this. View Entire Post ›
40 Travel Products Under $20 That Are Worth Every Penny
These silicone bottle covers and these clear waterproof shoe bags are things you get yourself now so you can thank yourself later. View Entire Post ›
After decades of false starts, the 1914 Hotel Clark finally reopens in downtown L.A.
Since the 1990s, the Beaux-Arts hotel has been called 'zombie building' because of its idleness. But with the Olympics coming and changes happening downtown, its owner believes now is the time to welcome guests in again.
31 Versatile Travel Products You’ll Genuinely Want To Use For Dozens Of Different Trips
Once you make it through one trip with this pill organizer, it'll become your new travel buddy. View Entire Post ›
Get Ready To Be Called "Mary Poppins" — 27 Teensy Tiny Travel-Sized Items That'll Fit In Your Purse
You’re always gonna be prepared. View Entire Post ›
These 33 Handy Travel Products Won’t Dig Into Your Vacation Budget, But They *Will* Make The Journey Way Easier
This handheld luggage scale will def save you come weigh in at the airport. View Entire Post ›
If You Can Pass This Geography Trivia Quiz, You Belong In The Knowledge Hall Of Fame
Test your knowledge of geography! View Entire Post ›
Heading to France? Amid Recent Unrest, Here’s What to Know
Demonstrations are expected to continue this weekend in Paris and other French cities. Some museums and tourist sites will be closed, and visitors should expect a strong police presence.
A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Visa Partners Singapore Tourism Board to Strengthen Singapore’s Global Destination Appeal
Visa, a global leader in digital payments and the Singapore Tourism Board (STB) have signed a three-year Memorandum of Understanding (MOU) to strengthen Singapore’s appeal as a preferred travel destination and to unlock new growth opportunities. The collaboration will focus on three key pillars – driving discovery of Singapore’s tourism products, especially its dining and night-time experiences; deriving insights to identify high-value tourism opportunities; and developing co-branded marketing campaigns to build brand preference for both Visa and Singapore.
Inside the red-hot REM hotel in Macau – think revolving beds and dreamlike suites
Melco Resorts & Entertainment’s newest hotel, REM, opened this week to complete the ultra-luxury trio at the City of Dreams in Macau. Rebranded from the Countdown Hotel, which was the Hard Rock Hotel before that, the property sits alongside the Zaha Hadid-designed Morpheus and Asian-inspired Nuwa, positioning itself as the most exclusive of the three. REM stands for rapid eye movement, the phase of sleep during which “we have the most vivid dreams”, said Lawrence Ho Yau-lung, chairman and CEO of...
L.A. Affairs: Could I pull off a red bikini at 55? My husband's deep love helped me love myself
As a woman in her 50s living in youth-obsessed Los Angeles, I was well aware of my age. Thankfully, my husband still gazes at me with desire and love.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.